Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 3, 2003, Pages 433-438

  Carp, H ^a,b   Dolitzky, M ^a   Inbal, A ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Enoxaparin; Hypercoagulability; Loss; Recurrent pregnancy; Thrombophilia

Indexed keywords

ENOXAPARIN; FIBRINOLYTIC AGENT;

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY HEALTH; FEMALE; GENETICS; HUMAN; KARYOTYPING; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RECURRENT ABORTION; THROMBOPHILIA; THROMBOSIS;

ABORTION, HABITUAL; ADULT; BIRTH RATE; ENOXAPARIN; FAMILY HEALTH; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; KARYOTYPING; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA; THROMBOSIS;

EID: 0141503825     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00066.x     Document Type: Article

References (37)

1. Salat-Baroux J. Recurrent spontaneous miscarriages. Reprod Nutr Dev 1998; 28: 1555-68.
2. Crosignani PC, Rubin BL. Recurrent spontaneous miscarriage. The recommendations of the ESHRE workshop on recurrent spontaneous miscarriage held in Anacapri on September 9-11 1990. Hum Reprod 1991; 6: 609-10.
3. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of Anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069-73.
4. DeWolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829-34.
5. Preston FE, Rosendaal FR, Walker ID, Briot E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, Van der Meer FJ. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913-6.
6. Grandone E, Margaglione M, Colaizzo D, D'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G, Di Minno G. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997; 77: 822-4.
7. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated C resistance. Br J Haematol 1996; 92: 489-90.
8. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000; 343: 1015-8.
9. Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod 1999; 14: 1624-7.
10. Younis JS, Ohel G, Brenner B, Ben-Ami M. Familial thrombophilia - the scientific rationale for thrombophylaxis in recurrent pregnancy loss. Hum Reprod 1997; 12: 1389-90.
11. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Hemost 2000; 83: 693-7.
12. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S. Factotr V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 32: 1283-8.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215-7.
14. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U. Single and combined prothrombothic factors in patients with idiopathic venous thromboembolism. Arterioscler Thromb Vasc Biol 1999; 19: 511-8.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Den Heijer M, Kluijtmans LA, Van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
16. Poort SR, Rosendahl FR, Reissma PH, Bertina RM. A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels, and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
17. Carp HJA, Toder V, Mashiach S. Immunotherapy of habitual abortion. Am J Reprod Immunol 1993; 28: 281-4.
18. Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide Collaborative Observational Study and Metaanalysis On Allogenic Leucocyte Immunotherapy For Recurrent Spontaneous Abortion. Am J Reprod Immunol 1994; 32: 55-72.
19. Daya S, Gunby J. The effectiveness of allogeneic leucocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32: 294-302.
20. Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, Blumenfeld Z. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997; 97: 551-4.
21. Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998; 128: 100-3.
22. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, Regan L. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 2001; 16: 961-5.
23. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 2001; 45: 65-71.
24. Dizon-Townson DS, Kinney S, Branch DW, Wand K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997; 34: 217-23.
25. Holmes ZR, Regan L, Chilcott I, Cohen H. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br J Haematol 1999; 105: 98-101.
26. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early forst-trimester recurrent pregnancy loss. Fertil Steril 1998; 71: 1048-54.
27. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, Yamada T, Sakuragi N, Fujimoto S. Recurrent pregnancy loss: etiology of thrombophilia. Semin Thromb Hemost 2001; 27: 121-9.
28. Carp HJA, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Human Reprod 2002; 17: 1633-7.
29. Ogasawara MS, Aoki K, Katano K, Ozaki Y, Suzumori K. Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril 2001; 75: 916-9.
30. Carp HJA, Dolitzky M, Tur-Kaspa I, Inbal A. Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage. Fertil Steril 2002; 78: 58-62.
31. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1258-65.
32. Ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost 1999; 82: 713-7.
33. Stern JJ, Dorfman AD, Gutierez-Najar MD. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65: 250-3.
34. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 73: 300-4.
35. Carp HJA, Toder V, Orgad, S, Aviram A, Danieli M, Mashiach S, Barkai G. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001; 75: 678-82.
36. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002; 77: 342-7.
37. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96: 45-9.